Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced financial results for the first quarter of fiscal year 2015, which ended September 30, 2014.
“We are pleased with our first quarter results, highlighted by double-digit EBITDA growth within two of our three reporting segments”
First quarter 2015 revenue of $418.3 million increased 1%, both as-reported and in constant currency, from $414.3 million in the first quarter a year ago.
Help employers find you! Check out all the jobs and post your resume.
“We are pleased with our first quarter results, highlighted by double-digit EBITDA growth within two of our three reporting segments”
First quarter 2015 revenue of $418.3 million increased 1%, both as-reported and in constant currency, from $414.3 million in the first quarter a year ago.
Help employers find you! Check out all the jobs and post your resume.
